Загрузка...
Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy
BACKGROUND: The effect of chemotherapy combined with monoclonal antibodies (mAbs) on the immune state of the tumor environment remains unclear and controversial. The aim of this study is to examine the effect of chemotherapy combined with cetuximab (C225, an anti-EGFR mAb) on the immune state of tum...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3847707/ https://ncbi.nlm.nih.gov/pubmed/24028754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-11-226 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|